At-home HPV testing boosts cervical cancer screening participation

Mailed at-home self-sampling for human papillomavirus (HPV) testing will increase cervical most cancers screening participation in underscreened populations by virtually threefold, in accordance with a research introduced on the annual assembly of the American Affiliation for Most cancers Analysis, held from April 5 to 10 in San Diego.

Jane R. Montealegre, Ph.D., from the College of Texas MD Anderson Most cancers Heart in Houston, and colleagues evaluated the effectiveness of mailed at-home self-sampling for HPV testing in a safety-net well being system setting. The evaluation included knowledge from 2,115 sufferers who had been randomly assigned to one of many three following arms: phone recall to provider-performed screening (normal care; arm 1); phone recall + mailed self-sampling package for HPV testing (arm 2); or phone recall + mailed self-sampling package + telephone-based affected person navigation (arm 3).

The researchers discovered that amongst contributors, the median time since final screening take a look at was 9.5 years. Screening participation throughout arms 1, 2, and three was 15.3, 44.0, and 51.4 p.c, respectively. In contrast with normal care (arm 1), the relative incidence of screening in arms 2 and three was 2.90 and three.36, respectively. For arm 3 versus arm 2, the relative incidence of screening was 1.16.

“After U.S. Meals and Drug Administration approval, self-sampling for high-risk-HPV testing has the potential to dramatically improve participation in cervical most cancers screening in underserved populations,” the authors write.

Copyright © 2024 HealthDay. All rights reserved.